TCRX

NASDAQStock

TScan Therapeutics, Inc.

$1.05-0.07 (-6.64%)

52-Week Range

$0.90

$2.52

Key Stats

Market Cap

59.9M

P/E Ratio

—

Dividend Yield

—

Beta

1.03

Volume

534.0K

Avg Volume

574.6K

Performance

+20.95%

+17.37%

-33.14%

YTD

+10.78%

-35.06%

-59.21%

-88.71%

Price Chart

ETF Exposure

TCRX is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.01%	116,800	$134K	$1.27B	0.60%
VXF	Vanguard Extended Market ETF	0.00%	577,585	$589K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	73	$102	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,635	$4K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	12	$17	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,500,337	$1.5M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	7,891	$11K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	680	$939	$1.29B	0.17%

About TCRX ETF Exposure

TScan Therapeutics, Inc. (TCRX) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 59.9M, TCRX is a widely held institutional stock. The stock currently trades at $1.05. Investors can gain exposure to TCRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TCRX, sorted by portfolio weight.